WordNet

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

Ferrando M1, Bagnasco D1, Varricchi G2, Bernardi S1, Bragantini A1, Passalacqua G1, Canonica GW3.
Allergy, asthma & immunology research.Allergy Asthma Immunol Res.2017 Jan;9(1):15-24. doi: 10.4168/aair.2017.9.1.15.
Allergic disease is among the most common pathologies worldwide and its prevalence has constantly increased up to the present days, even if according to the most recent data it seems to be slightly slowing down. Allergic disease has not only a high rate of misdiagnosis and therapeutic inefficacy, bu
PMID 27826958

Long-acting injectable antipsychotics for the prevention of relapse in patients with recent-onset psychotic disorders: A systematic review and meta-analysis of randomized controlled trials.

Kishi T1, Oya K2, Iwata N2.
Psychiatry research.Psychiatry Res.2016 Dec 30;246:750-755. doi: 10.1016/j.psychres.2016.10.053. Epub 2016 Nov 3.
This meta-analysis of randomized controlled trials (RCTs) investigated the advantages of long-acting injectable antipsychotics (LAI-APs) over oral antipsychotics (OAPs) with regard to efficacy and safety for patients with recent-onset psychotic disorders. Effect sizes and 95% confidence intervals (9
PMID 27863801

Long-term safety of icatibant treatment of patients with angioedema in real-world clinical practice.

Zanichelli A1, Maurer M2, Aberer W3, Caballero T4, Longhurst H5, Bouillet L6, Fabien V7, Andresen I7; IOS Study Group.
Allergy.Allergy.2016 Dec 7. doi: 10.1111/all.13103. [Epub ahead of print]
The Icatibant Outcome Survey (IOS) is an observational study monitoring safety and effectiveness of icatibant in the real-world setting. We analyzed safety data from 3025 icatibant-treated attacks in 557 patients (enrolled between July 2009 and February 2015). Icatibant was generally well tolerated.
PMID 27926986

Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy.